-
+22 +1
Rare footage of 1950's housewife on LSD
One of my favourite clips about some of my favourite experiences. Sort of.
-
+16 +1
Family Trip
A mother (Michelle) and her daughter (Lacey) take a therapeutic dose of MDMA with an experienced facilitator (Mikaela) in an attempt to heal generational trauma created by addiction, neglect, racism, divorce and alcoholism. As they begin to peak they are joined by Lacey's children, bringing together 3 generations as they dive deeper into forgiveness, acceptance and forging a new vision for their future. Many thanks to Mikaela and the family for their extreme generosity in allowing us to bear witness to this extraordinary experience.
-
+25 +1
Using psychedelics to treat depression and trauma
Using psychedelics to treat depression and trauma has just become legal in Australia. Offering hope to many, it’s not without risk. While many report life-changing benefits, others do not, and many scientists in the field fear the move is premature.
-
+30 +1
Friday essay: peyotes in suburbia – the secret world of Sydney's psychoactive cacti growers
They tend backyards brimming with cactus varieties, consuming the produce. Prudence Gibson meets a hidden group of gardeners and ponders the allure – and – danger of psychoactive plants.
-
+2 +1
Psychedelic therapy may be better than conventional depression and anxiety treatments for patients with advanced cancer
In people with advanced cancer, psychedelic drugs like psilocybin, LSD and MDMA may significantly reduce the severity of depression and anxiety symptoms. Roughly 10% of patients with cancer experience anxiety, while 20% report depression. However, current research suggests that available prescription antidepressants do not significantly decrease depressive symptoms in cancer patients compared with a placebo.
-
+30 +1
How Psilocybin Mushrooms Can Be Used to Treat Depression
Depression is becoming increasingly prevalent, with an estimated 5% of adults suffering from this mental health condition globally. The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) sets out multiple criteria for clinical depression. These include persistent low mood nearly every day for a period longer than 2 weeks and diminished ability to concentrate.
-
+13 +1
Psychedelics may treat depression by invading brain cells
Psychedelic drugs have shown promise as therapies for hard-to-treat depression. Now, scientists have a potential explanation for why: The drugs may be able to slip through the outer membranes of brain cells and essentially flip switches inside the cells that other depression treatments can't.
-
+2 +1
Scientists are finally taking a serious look at psilocybin for the treatment of cluster headaches
The results from the first randomized, double-blind, placebo-controlled study to systematically investigate the effects of psilocybin in cluster headache has been published in the scientific journal Headache. The initial study provides useful information for creating bigger and more conclusive studies in the future.
-
+16 +1
Psychedelic Assisted Therapy
John Oliver discusses psychedelic assisted therapy: its history, its potential, and what it has to do with A$AP Rocky’s relationship to rainbows.
-
+14 +1
Study suggests psilocybin increases mindfulness, especially when accompanied by mystical experiences
Arecent study published in Frontiers in Psychology investigates the relationship between psilocybin, mindfulness, mystical-type experiences, and serotonin receptors in the brain. Following participants for three months after a dose of psilocybin, the new findings indicate that when taking psilocybin, those who report mystical-type experiences are more likely to have increased trait mindfulness.
-
+14 +1
Psychedelic drugs may launch a new era in psychiatric treatment, brain scientists say
One of the hottest tickets at this year's Society for Neuroscience meeting in San Diego was a session on psychedelic drugs. About 1,000 brain scientists squeezed into an auditorium at the San Diego Convention Center for the symposium, called Psychedelics and Neural Plasticity.
-
+3 +1
Up to 9% of LSD and psilocybin users report reoccurring effects after drug has worn off
New research published in the journal Psychopharmacology explored the occurrence of flashback phenomena — drug-like effects that spontaneously recur following hallucinogen exposure. The results from six placebo-controlled studies revealed that flashback phenomena occurred for up to 9.2% of participants after LSD or psilocybin exposure.
-
+21 +1
Magic mushroom compound psilocybin can help treat depression, study finds
The naturally occurring psychedelic compound psilocybin can significantly reduce symptoms of depression, according to data from the largest trial of its type ever conducted. Psilocybin was given to 233 patients who had already tried at least two antidepressants in the past with little success, suggesting the compound could have huge benefits for those suffering with hard-to-treat depression.
-
+19 +1
Manipulating light can induce psychedelic experiences – and scientists aren't quite sure why
For millennia, people have used mind-altering techniques to achieve different states of consciousness, envision spiritual figures, connect with nature, or simply for the fun of it. Psychedelic substances, in particular, have a long and controversial history. But for just as long, people have been having these experiences without drugs too, using rhythmic techniques such as rocking, chanting or drumming.
-
+19 +1
New research suggests psychedelic drugs can be almost as life altering as near-death experiences
Occasionally, people who suffer intense turmoil and trauma undergo a profound change. They feel a new sense of wellbeing, purpose and appreciation of life. Their relationships become more authentic and intimate. They feel as if they’ve woken up and are living in a more intense way.
-
+4 +1
The High-Stakes Race to Engineer New Psychedelic Drugs
As psychedelic therapies for mental health go mainstream, companies are recruiting chemists to create patentable versions of hallucinogens. Critics say it’s all a bad trip.
-
+4 +1
San Francisco Launches Bid to Decriminalize Psychedelics
City lawmakers in San Francisco have introduced a resolution to decriminalize naturally occurring psychedelics, or “entheogens.” The measure would remove criminal penalties for possession of drugs like psilocybin or mescaline—both to reduce criminalization in itself, and to make it easier for people to use these drugs for therapeutic purposes. If successful, San Francisco would join a growing list of cities to adopt similar measures, including Denver, Oakland, Seattle, Detroit and Washington, DC.
-
+15 +1
Biden Administration Plans for Legal Psychedelic Therapies Within Two Years
AS TWIN MENTAL HEALTH and drug misuse crises kill thousands of people per week, the potential of psychedelic-assisted therapies “must be explored,” urges a federal letter on behalf of the U.S. health secretary and shared with The Intercept.
-
+3 +1
A single dose of psilocybin has long-lasting antidepressant-like effects in fruit flies
Scientists have taken an important first step into studying the effects of the psychedelic drug psilocybin -- the active substance in "magic" mushrooms -- at a cellular and genetic level.
-
+18 +1
Psychedelics May Be Your Ticket To Self-Actualization, Says New Research
Psychedelic substances may take us places that standard treatment hasn’t yet.
Submit a link
Start a discussion